Evaluation of an Enzyme Immunometric Assay to Measure Serum Adiponectin Concentrations

Clinical Chemistry

Volumn 50, Issue 1, 2004, Pages 219-221

  Suominen, Pauli ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; QUESTIONNAIRE;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROTEINS; RADIOIMMUNOASSAY; SERUM;

EID: 1642533456     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.025833     Document Type: Article

References (15)

1. Scherer PE, Williams S, Fogliano M. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-9.
2. Maeda K, Okubo K, Schimomura I. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996;221:286-9.
3. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999;38:202-6.
4. Aldhahi W, Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 2003;3:293-8.
5. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hyperadiponectinemia in obesity and type 2 diabetes: close associatin with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
6. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of adiponectin mutation with type 2 diabetes. Diabetes 2002;51:2325-8.
7. Pellme F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, et al. Circulating adiponectin levels are reduced in non-obese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 2003;52:1182-6.
8. Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus [Erratum published in Lancet 2002;361:1060]. Lancet 2002;361:226-8.
9. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52:239-43.
10. Daimon M, Yamaguchi H, Oizumi T, Ohnuma H, Saitoh T, Igarashi M, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. Diabetes Care 2003;26:2015-20.
11. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-6.
12. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003;88:3236-40.
13. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte, derived macrophages. Circulation 2001;102:1057-63.
14. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis - the missing link of adipovascular axis. J Biol Chem 2002;277:37487-91.
15. Martin RF. General Deming regression for estimating systemic bias and its confidence interval in method-comparison studies. Clin Chem 2000;46:100-4.